Sharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2026 ,inter alia, to consider and approve 1. To approve IND-AS compliant Standalone Un-audited Financial Results along with Limited Review Report for the quarter ended on 30th September 2026 pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements), Regulations 2015. 2. ....

SHARMA EAST INDIA HOSPITALS AND MEDICAL RESEARCH LTD. Regd. Office: Jaipur Hospital, Near SMS Stadium, Lal Kothi, Tonk Road, Jaipur-302015 (Raj.) Phone: 0141-2742557, 2742266 CIN: L85110RJ1989PLC005206 E-Mail: sharmaeastindia@gmail.com Website: www.jaipurhospital.co.in November 3, 2026 The Manager, Corporate Relationship Department, BSE Ltd. 25th Floor PJ. Towers, Dalal Street, Fort, Mumbai-400 001 Subject.: Intimation under i isti igations and Disclosure Requiir ements) Regullaattii ons 201155 ffio r holdii ng Board MMeeeettii ng forr ApprApoprvovaall ofof Un-UnA-uAdudiitteedd financial results for the Quarter and half year ended 30% September 2026 and other ma;gers Ref: Scrip Code: - 524548 Dear Sir, This is to inform you that, the meeting of the Board ofD irectors of Sharma East India Hospitals & Medical Research Limited is scheduled to be held on Saturday, November 7, 2026, at the registered office of the Company, to transact inter alia, the following business: 1 To approve IND-AS compliant Standalone Un-audited Financial Results along with Limited Review Report for the quarter and half year ended on 30t September 2026 pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, 2 Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director. Further, as communicated earlier, in accordance with Company’s Code of Conduct for Prevention of Insider Trading in securities of the Company and pursuant to the SEBI (Prohibition ofI nsider Trading) Regulations, 2015, the Trading Window for dealing in securities of the Company is already closed from Thursday, 1+ October 2026 until Forty-Eight (48) hours after declaration of un-audited financial results for the quarter and half year ended on 30 September 2026, on stock exchange. Kindly take it on record and acknowledge the same. Thanking You, For SHARMA E, INDIA HOSPITALS & MEDICAL RESEARCH LIMITED Bhawaria Sharma (Company Secretary And Compliance Officer) M. No.A61665 Place: Jaipur